Stada Boards Back Sweetened €4.12B Bain, Cinven Buyout
German pharmaceutical company Stada Arzneimittel AG on Tuesday encouraged shareholders to accept a sweetened €4.12 billion ($4.8 billion) takeover offer from Bain Capital and Cinven, after an earlier buyout offer from...To view the full article, register now.
Already a subscriber? Click here to view full article